Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor

被引:124
作者
Cunnick, JM
Dorsey, JF
Munoz-Antonia, T
Mei, L
Wu, J
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program MRC 3057E, Tampa, FL 33612 USA
[2] Univ S Florida, Dept Med Microbiol & Immunol, Tampa, FL 33612 USA
[3] Univ S Florida, Dept Biochem & Mol Biol, Tampa, FL 33612 USA
[4] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA
关键词
D O I
10.1074/jbc.275.18.13842
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Grb2-associated binder-1 (Gab1) is a multisite docking protein containing a pleckstrin homology (PH) domain, multiple potential tyrosine phosphorylation sites, and several proline-rich sequences. Gab1 becomes tyrosine-phosphorylated in cells stimulated with growth factors, cytokines, and ligands for G protein-coupled receptors, A major Gab1-binding protein detected in cells treated with extracellular stimuli is the tyrosine phosphatase, SHP2. Although the role of SHP2-Gab1 interaction in cell signaling has not yet been characterized, SHP2 is known to mediate mitogen-activated protein (MAP) kinase activation induced by the epidermal growth factor (EGF), However, the mechanism by which the SHP2 phosphatase exerts a positive signaling role remains obscure. In this study, we prepared Gab1 mutants lacking the SHP2 binding site (Gab1Y627F), the phosphatidylinositol 3-kinase (PI3K) binding sites (Gab1 Delta PI3K), and the PH domain (Gab1 Delta PH). Expression of Gab1Y627F blocked the extracellular signal-regulated kinase-2 (ERK2) activation by lysophosphatidic acid (LPA) and EGF, Conversely, expression of the wild-type Gab1 in HEK293 cells augmented the LPA receptor Edg2-mediated ERK2 activation. Whereas the PH domain was required for Gab1 mediation of ERR2 activation by LPA, it was not essential for EGF-induced ERK2 activation. Expression of Gab1 Delta PI3K had no apparent effect on ERK2 activation by LPA and EGF in the cells that we have examined. These results establish a role for Gab1 in the LPA-induced MAP kinase pathway and clearly demonstrate that Gab1-SHP2 interaction is essential for ERK2 activation by LPA and EGF. These findings also suggest that the positive role of SHP2 in the MAP kinase pathway depends on its interaction with Gab1.
引用
收藏
页码:13842 / 13848
页数:7
相关论文
共 38 条
[21]   LYSOPHOSPHATIDIC ACID, A MULTIFUNCTIONAL PHOSPHOLIPID MESSENGER [J].
MOOLENAAR, WH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :12949-12952
[22]   Lysophosphatidic acid: G-protein signalling and cellular responses [J].
Moolenaar, WH ;
Kranenburg, O ;
Postma, FR ;
Zondag, GCM .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :168-173
[23]   Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors [J].
Nishida, K ;
Yoshida, Y ;
Itoh, M ;
Fukada, T ;
Ohtani, T ;
Shirogane, T ;
Atsumi, T ;
Takahashi-Tezuka, M ;
Ishihara, K ;
Hibi, M ;
Hirano, T .
BLOOD, 1999, 93 (06) :1809-1816
[24]   ROLE OF SH-PTP2, A PROTEIN-TYROSINE-PHOSPHATASE WITH SRC HOMOLOGY-2 DOMAINS, IN INSULIN-STIMULATED RAS ACTIVATION [J].
NOGUCHI, T ;
MATOZAKI, T ;
HORITA, K ;
FUJIOKA, Y ;
KASUGA, M .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) :6674-6682
[25]   SH2 AND SH3 DOMAINS - FROM STRUCTURE TO FUNCTION [J].
PAWSON, T ;
GISH, GD .
CELL, 1992, 71 (03) :359-362
[26]  
PICHER JA, 1995, J BIOL CHEM, V270, P11707
[27]   Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules [J].
Rocchi, S ;
Tartare-Deckert, S ;
Murdaca, J ;
Holgado-Madruga, M ;
Wong, AJ ;
Van Obberghen, E .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (07) :914-923
[28]  
Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435
[29]   Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase [J].
Takahashi-Tezuka, M ;
Yoshida, Y ;
Fukada, T ;
Ohtani, T ;
Yamanaka, Y ;
Nishida, K ;
Nakajima, K ;
Hibi, M ;
Hirano, T .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) :4109-4117
[30]  
Tanowitz M, 1999, J NEUROSCI, V19, P9426